Athene Holding Ltd. Class A Common Shares (ATH): Price and Financial Metrics

Athene Holding Ltd. Class A Common Shares (ATH)

Today's Latest Price: $34.24 USD

0.47 (1.39%)

Updated Oct 23 7:00pm

Add ATH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 8 in Insurance - Reinsurance

See all "A" rated Strong Buy stocks

ATH Stock Summary

  • Of note is the ratio of Athene Holding Ltd's sales and general administrative expense to its total operating expenses; merely 0.34% of US stocks have a lower such ratio.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 11.95 for Athene Holding Ltd; that's greater than it is for 95.52% of US stocks.
  • As for revenue growth, note that ATH's revenue has grown -47.13% over the past 12 months; that beats the revenue growth of just 4.57% of US companies in our set.
  • Stocks that are quantitatively similar to ATH, based on their financial statements, market capitalization, and price volatility, are CNA, FANG, SJR, PTVCB, and XEC.
  • Visit ATH's SEC page to see the company's official filings. To visit the company's web site, go to

ATH Stock Price Chart Interactive Chart >

Price chart for ATH

ATH Price/Volume Stats

Current price $34.24 52-week high $50.43
Prev. close $33.77 52-week low $13.37
Day low $33.65 Volume 1,180,544
Day high $34.51 Avg. volume 1,969,952
50-day MA $35.71 Dividend yield N/A
200-day MA $33.78 Market Cap 6.65B

Athene Holding Ltd. Class A Common Shares (ATH) Company Bio

Athene Holding Ltd., a retirement services company, issues, reinsures, and acquires retirement savings products designed for individuals and institutions seeking to fund retirement needs in the United States, the District of Columbia, and Germany. It offers retail fixed and equity indexed annuity products; co-insurance and reinsurance arrangements with third-party annuity providers; and institutional products, such as funding agreements. The company was founded in 2008 and is based in Pembroke, Bermuda.

ATH Latest News Stream

Event/Time News Detail
Loading, please wait...

ATH Latest Social Stream

Loading social stream, please wait...

View Full ATH Social Stream

Latest ATH News From Around the Web

Below are the latest news stories about Athene Holding Ltd that investors may wish to consider to help them evaluate ATH as an investment opportunity.

American Equity Confirms Receipt of Unsolicited Non-Binding Acquisition Proposal

WEST DES MOINES, Iowa--(BUSINESS WIRE)--American Equity Investment Life Holding Company (NYSE: AEL) today confirmed that it received an unsolicited non-binding proposal from Athene Holding Ltd. (NYSE: ATH) with Massachusetts Mutual Life Insurance Company to acquire all outstanding common shares of American Equity for $36.00 per share in cash. Consistent with its fiduciary responsibilities, American Equity’s Board of Directors is carefully reviewing the unsolicited proposal in consultation with

Business Wire | October 1, 2020

Athene Holding Ltd. Appoints Lynn Swann to Board of Directors

PEMBROKE, Bermuda--(BUSINESS WIRE)--Athene Holding Ltd. Appoints Lynn Swann to Board of Directors

Business Wire | September 17, 2020

Athene Holding Ltd.'s (ATH) CEO James Belardi on Q2 2020 Results - Earnings Call Transcript

Athene Holding Ltd. (ATH) Q2 2020 Earnings Conference Call August 5, 2020 10:00 AM ET Company Participants Noah Gunn - Head-Investor Relations James Belardi - Chief Executive Officer, Chief Investment Officer and Co-Founder William Wheeler - President Martin Klein - Chief Financial Officer Conference Call Participants Thomas Gallagher - Evercore...

SA Transcripts on Seeking Alpha | August 9, 2020

The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD ) (FDA approved the emergency use of Abiomed's Impella heart pump in combination with an oxygen machine to treat Covid-19 patients who suffer heart and lung failure) Allovir Inc (NASDAQ: ALVR ) (IPOed Thursday) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced positive preclinical data for its lead drug in Multiple System Atrophy) ALX Oncology Holdings Inc (NASDAQ: ALXO ) Cardiff Oncology Inc (NASDAQ: CRDF ) Cocrystal Pharma Inc (NASDAQ: COCP ) (announced the publication of positive preclinical animal studies of coronavirus antiviral compounds in a medical journal) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fulgent Genetics Inc (NASDAQ: FLGT ) Hologic, Inc. (NASDAQ: HOLX ) Inari Medical Inc (NA...

Benzinga | August 5, 2020

Athene Holding Ltd. Reports Second Quarter 2020 Results

PEMBROKE, Bermuda--(BUSINESS WIRE)--Athene Holding Ltd. Reports Second Quarter 2020 Results

Business Wire | August 5, 2020

Read More 'ATH' Stories Here

ATH Price Returns

1-mo 3.76%
3-mo 2.55%
6-mo 35.34%
1-year -18.48%
3-year -35.58%
5-year N/A
YTD -27.20%
2019 18.08%
2018 -22.97%
2017 7.75%
2016 N/A
2015 N/A

Continue Researching ATH

Here are a few links from around the web to help you further your research on Athene Holding Ltd's stock as an investment opportunity:

Athene Holding Ltd (ATH) Stock Price | Nasdaq
Athene Holding Ltd (ATH) Stock Quote, History and News - Yahoo Finance
Athene Holding Ltd (ATH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7747 seconds.